Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Volume for mTLIP Block in Lumbar Spine Surgery
NCT05276908Completed
- Sponsor
- Cairo University
- Start
- Mar 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Total morphine consumption in the first 24 hours postoperative. Started Mar 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05276908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05276908.